Novartis Ag (NVSEF) Depreciation & Amortization - Total (2009 - 2014)
Novartis Ag (NVSEF) posted Depreciation & Amortization - Total of $275.0 for Q1 2010, down 57.69% sequentially from $650.0 in Q4 2009, and down 18.64% YoY from $338.0 in Q1 2009.
Novartis Ag (NVSEF) Depreciation & Amortization - Total (2009 - 2014) Analysis & Trends
Novartis Ag (NVSEF) has 2 years of Depreciation & Amortization - Total data on file, last reported at $275.0 in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Novartis Ag | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1,652.00 |
| Dec 31, 2013 | -1,755.00 |
| Mar 31, 2011 | 426.00 |
| Dec 31, 2010 | -1.36 Bn |
| Mar 31, 2010 | 275.00 |
| Dec 31, 2009 | -1.24 Bn |
| Mar 31, 2009 | 338.00 |